NUTM2E
gene geneOn this page
Summary
NUTM2E (NUT family member 2E, HGNC:23448) is a protein-coding gene on chromosome 10q22.3, encoding NUT family member 2E (B1AL46).
At a glance
- Clinical variants (ClinVar): 6 total
- MANE Select transcript:
NM_001355263
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23448 |
| Approved symbol | NUTM2E |
| Name | NUT family member 2E |
| Location | 10q22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000228570 |
| Ensembl biotype | protein_coding |
| Entrez | 283008 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000429984, ENST00000602967
RefSeq mRNA: 1 — MANE Select: NM_001355263
NM_001355263
CCDS: CCDS91285
Canonical transcript exons
ENST00000429984 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002441976 | 79848513 | 79848895 |
| ENSE00002450251 | 79849821 | 79850878 |
| ENSE00002467773 | 79846830 | 79846958 |
| ENSE00002483375 | 79849371 | 79849487 |
| ENSE00002498825 | 79844173 | 79844872 |
| ENSE00002517775 | 79847931 | 79848070 |
| ENSE00003918438 | 79826739 | 79827357 |
| ENSE00003918568 | 79839628 | 79842122 |
| ENSE00003920477 | 79838309 | 79838586 |
| ENSE00003920727 | 79838780 | 79839115 |
Expression profiles
Bgee: expression breadth ubiquitous, 119 present calls, max score 60.77.
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 60.77 | silver quality |
| stromal cell of endometrium | CL:0002255 | 60.55 | gold quality |
| apex of heart | UBERON:0002098 | 57.04 | gold quality |
| primary visual cortex | UBERON:0002436 | 55.24 | gold quality |
| right uterine tube | UBERON:0001302 | 53.05 | gold quality |
| ventricular zone | UBERON:0003053 | 52.04 | gold quality |
| colonic epithelium | UBERON:0000397 | 51.22 | gold quality |
| blood | UBERON:0000178 | 50.06 | gold quality |
| prefrontal cortex | UBERON:0000451 | 49.86 | gold quality |
| tonsil | UBERON:0002372 | 48.61 | silver quality |
| islet of Langerhans | UBERON:0000006 | 48.01 | gold quality |
| muscle tissue | UBERON:0002385 | 47.07 | gold quality |
| cortical plate | UBERON:0005343 | 46.72 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 46.56 | gold quality |
| lymph node | UBERON:0000029 | 46.41 | gold quality |
| fundus of stomach | UBERON:0001160 | 46.02 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 45.95 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 45.76 | gold quality |
| frontal cortex | UBERON:0001870 | 45.55 | gold quality |
| granulocyte | CL:0000094 | 45.20 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 45.12 | gold quality |
| pancreas | UBERON:0001264 | 45.10 | gold quality |
| monocyte | CL:0000576 | 44.57 | silver quality |
| ganglionic eminence | UBERON:0004023 | 44.27 | gold quality |
| duodenum | UBERON:0002114 | 44.20 | gold quality |
| liver | UBERON:0002107 | 44.18 | silver quality |
| cerebellum | UBERON:0002037 | 44.06 | gold quality |
| adenohypophysis | UBERON:0002196 | 43.94 | gold quality |
| leukocyte | CL:0000738 | 43.89 | silver quality |
| cerebellar cortex | UBERON:0002129 | 43.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.34 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Studies show that patients with clear cell sarcoma of the kidney (CCSK) and the fusion YWHAE-NUTM2B/E were relatively young, had low tumor volumes, and did not present with stage I disease which fail to identify an explicit clinical phenotype. (PMID:26542179)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Nutm2 | ENSMUSG00000071909 |
| rattus_norvegicus | Nutm2 | ENSRNOG00000027311 |
Paralogs (6): NUTM2F (ENSG00000130950), NUTM1 (ENSG00000184507), NUTM2A (ENSG00000184923), NUTM2G (ENSG00000188152), NUTM2B (ENSG00000188199), NUTM2D (ENSG00000214562)
Protein
Protein identifiers
NUT family member 2E — B1AL46 (reviewed: B1AL46)
All UniProt accessions (2): B1AL46, R4GNA6
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the NUT family.
RefSeq proteins (1): NP_001342192* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024309 | NUT_N | Domain |
| IPR024310 | NUT | Family |
Pfam: PF12881
UniProt features (10 total): region of interest 5, compositionally biased region 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B1AL46-F1 | 47.81 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP, JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN, chr10q22
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
372 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NUTM2E | YWHAE | P29360 | 518 |
| NUTM2E | ZC3H7B | Q9UGR2 | 461 |
| NUTM2E | CCNB3 | Q8WWL7 | 401 |
| NUTM2E | BRD8 | Q9H0E9 | 314 |
| NUTM2E | PHF1 | O43189 | 309 |
| NUTM2E | PHF21A | Q96BD5 | 309 |
| NUTM2E | LRP12 | Q9Y561 | 306 |
| NUTM2E | NOTCH2NLA | Q7Z3S9 | 278 |
| NUTM2E | RNF111 | Q6ZNA4 | 278 |
| NUTM2E | BCORL1 | Q5H9F3 | 269 |
| NUTM2E | JAZF1 | Q86VZ6 | 254 |
| NUTM2E | FBXO25 | Q8TCJ0 | 253 |
| NUTM2E | KAT6B | Q8WYB5 | 244 |
| NUTM2E | MEAF6 | Q9HAF1 | 236 |
| NUTM2E | IRX2 | Q9BZI1 | 234 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A1L443, A2IDD5, A5D7L8, A6NDY2, A6NIJ5, A6NNJ1, A6NNL0, A7E346, A8K0R7, A8MXJ8, A8MXZ1, B1AL46, B1ASB6, C9JSJ3, E9PGG2, O08574, P0C7V4, P0C7W8, P0C7X0, P0CG20, P0DV73, P0DV75, P0DV76, Q0VG99, Q0ZCJ7, Q149B8, Q2M3G4, Q3TQ03, Q3V0C3, Q4KLY2, Q5JXC2, Q5RCJ6, Q5SV97, Q5SW24, Q5VT03, Q5VZR2, Q6ZMY3
Diamond homologs: A1L443, A6NNL0, B1AL46, Q3V0C3, Q5VT03, Q5VZR2, Q86Y26, Q8BHP2, Q8IVF1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1225 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:79846828:A:AG | acceptor_gain | 1.0000 |
| 10:79846829:G:GT | acceptor_gain | 1.0000 |
| 10:79846829:GC:G | acceptor_gain | 1.0000 |
| 10:79846829:GCC:G | acceptor_gain | 1.0000 |
| 10:79846829:GCCC:G | acceptor_gain | 1.0000 |
| 10:79846829:GCCCA:G | acceptor_gain | 1.0000 |
| 10:79846954:GAAAA:G | donor_gain | 1.0000 |
| 10:79846955:AAAA:A | donor_gain | 1.0000 |
| 10:79846956:AAA:A | donor_gain | 1.0000 |
| 10:79846957:AA:A | donor_gain | 1.0000 |
| 10:79846957:AAGT:A | donor_loss | 1.0000 |
| 10:79846958:AGT:A | donor_loss | 1.0000 |
| 10:79846959:G:GG | donor_gain | 1.0000 |
| 10:79848512:GT:G | acceptor_gain | 1.0000 |
| 10:79848891:CCAAG:C | donor_loss | 1.0000 |
| 10:79848892:CAAG:C | donor_loss | 1.0000 |
| 10:79848893:AAG:A | donor_loss | 1.0000 |
| 10:79848894:AGGT:A | donor_loss | 1.0000 |
| 10:79848895:GGT:G | donor_loss | 1.0000 |
| 10:79848896:G:C | donor_loss | 1.0000 |
| 10:79849362:T:A | acceptor_gain | 1.0000 |
| 10:79849367:CCAG:C | acceptor_loss | 1.0000 |
| 10:79849368:CAGGT:C | acceptor_loss | 1.0000 |
| 10:79849369:A:AG | acceptor_gain | 1.0000 |
| 10:79849369:AG:A | acceptor_gain | 1.0000 |
| 10:79849369:AGGT:A | acceptor_gain | 1.0000 |
| 10:79849369:AGGTG:A | acceptor_gain | 1.0000 |
| 10:79849370:G:GA | acceptor_gain | 1.0000 |
| 10:79849370:GG:G | acceptor_gain | 1.0000 |
| 10:79849370:GGT:G | acceptor_gain | 1.0000 |
AlphaMissense
5614 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:79847932:T:C | F405L | 0.989 |
| 10:79847934:C:A | F405L | 0.989 |
| 10:79847934:C:G | F405L | 0.989 |
| 10:79847941:T:C | F408L | 0.988 |
| 10:79847943:T:A | F408L | 0.988 |
| 10:79847943:T:G | F408L | 0.988 |
| 10:79844865:T:C | F359L | 0.987 |
| 10:79844867:C:A | F359L | 0.987 |
| 10:79844867:C:G | F359L | 0.987 |
| 10:79846908:G:C | W387C | 0.985 |
| 10:79846908:G:T | W387C | 0.985 |
| 10:79846906:T:A | W387R | 0.983 |
| 10:79846906:T:C | W387R | 0.983 |
| 10:79847933:T:C | F405S | 0.980 |
| 10:79844796:T:A | W336R | 0.979 |
| 10:79844796:T:C | W336R | 0.979 |
| 10:79846939:T:C | F398L | 0.979 |
| 10:79846941:C:A | F398L | 0.979 |
| 10:79846941:C:G | F398L | 0.979 |
| 10:79844787:T:C | F333L | 0.978 |
| 10:79844789:C:A | F333L | 0.978 |
| 10:79844789:C:G | F333L | 0.978 |
| 10:79844798:G:C | W336C | 0.975 |
| 10:79844798:G:T | W336C | 0.975 |
| 10:79849395:T:C | F587L | 0.973 |
| 10:79849397:C:A | F587L | 0.973 |
| 10:79849397:C:G | F587L | 0.973 |
| 10:79844810:G:C | K340N | 0.972 |
| 10:79844810:G:T | K340N | 0.972 |
| 10:79844818:C:A | A343D | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000236357 (10:79825863 A>G), RS1000630059 (10:79839115 G>A), RS1000670512 (10:79826039 C>A,G,T), RS1000756928 (10:79832286 T>G), RS1001002094 (10:79838943 G>A), RS1001298151 (10:79835936 G>T), RS1001351323 (10:79828546 G>A), RS1001423575 (10:79829173 A>G), RS1001946692 (10:79825058 G>A), RS1002268837 (10:79837312 C>G), RS1002357792 (10:79830201 G>A), RS1002375147 (10:79837984 G>A), RS1002429785 (10:79830425 G>T), RS1002708023 (10:79837689 C>G), RS1002869104 (10:79845699 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.